Alemtuzumab as Graft-Versus-Host Disease (GVHD) Prophylaxis Strategy in a Developing Country: Lower Rate of Acute GVHD, Increased Risk of Cytomegalovirus Reactivation

Brazilian Journal of Medical and Biological Research - Brazil
doi 10.1590/1414-431x20165566

Related search